BMRB Entry 53420

Title:
Chemical Shift Assignment of ipilimumab variable light domain (VL)
Deposition date:
2025-11-06
Original release date:
2025-11-14
Authors:
Henot, Faustine; Vibert, Beatrice; Boisbouvier, Jerome; Frances, Oriane
Citation:

Citation: Henot, Faustine; Vibert, Beatrice; Giraud, Arthur; Dbira, Sarra; Imbert, Lionel; Favier, Adrien; Guntert, Peter; Clavier, Severine; Crublet, Elodie; Doyen, Camille; Boisbouvier, Jerome; Frances, Oriane. "A fast and efficient strategy for the NMR assignment of Fab methyl groups"  J. Biomol. NMR ., .-..

Assembly members:

Assembly members:
entity_1, polymer, 136 residues, Formula weight is not available

Natural source:

Natural source:   Common Name: Human   Taxonomy ID: 9606   Superkingdom: Eukaryota   Kingdom: Metazoa   Genus/species: Homo sapiens

Experimental source:

Experimental source:   Production method: cell free synthesis   Host organism: Escherichia coli   Vector: pIVEX 2.4d

Data sets:
Data typeCount
13C chemical shifts288
15N chemical shifts77
1H chemical shifts248

Time Domain Data

Additional metadata:

  • Assembly
  • Samples and Experiments
  • Software
  • Spectrometers
  • Hide all

Assembly:

Entity Assembly IDEntity NameEntity ID
1VL-ipilimumab1

Entities:

Entity 1, VL-ipilimumab 136 residues - Formula weight is not available

1   METSERGLYSERHISHISHISHISHISHIS
2   SERSERGLYILEGLUGLYARGGLYARGGLU
3   ASNLEUTYRPHEGLNGLYGLUILEVALLEU
4   THRGLNSERPROGLYTHRLEUSERLEUSER
5   PROGLYGLUARGALATHRLEUSERCYSARG
6   ALASERGLNSERVALGLYSERSERTYRLEU
7   ALATRPTYRGLNGLNLYSPROGLYGLNALA
8   PROARGLEULEUILETYRGLYALAPHESER
9   ARGALATHRGLYILEPROASPARGPHESER
10   GLYSERGLYSERGLYTHRASPPHETHRLEU
11   THRILESERARGLEUGLUPROGLUASPPHE
12   ALAVALTYRTYRCYSGLNGLNTYRGLYSER
13   SERPROTRPTHRPHEGLYGLNGLYTHRLYS
14   VALGLUILELYSARGTHR

Samples:

sample_1: Variable Light Domain (VL) from ipilimumab, [Met, Ala: 13CH3], 140 uM; MES 50 mM; NaCl 100 mM

sample_2: Variable Light Domain (VL) from ipilimumab, [Met / Ile-d1 / V-pro-S 13CH3], 95 uM; MES 50 mM; NaCl 100 mM

sample_3: Variable Light Domain (VL) from ipilimumab, [Met / Thr 13CH3], 108 uM; MES 50 mM; NaCl 100 mM

sample_4: Variable Light Domain (VL) from ipilimumab, [Met / Val-proS/Val-proR 13CH3], 45 uM; MES 50 mM; NaCl 100 mM

sample_5: Variable Light Domain (VL) from ipilimumab, [Met / Leu-proS 13CH3], 16 uM; MES 50 mM; NaCl 100 mM

sample_6: Variable Light Domain (VL) from ipilimumab, [U-100% 13C; U-100% 15N], 370 uM; MES 50 mM; NaCl 100 mM

sample_7: Variable Light Domain (VL) from ipilimumab, [U-100% 13C; U-100% 15N], 1.38 mM; MES 50 mM; NaCl 100 mM

sample_conditions_1: ionic strength: 0.125 M; pH: 6.9; pressure: 1 atm; temperature: 308 K

sample_conditions_2: ionic strength: 0.125 M; pH: 6.5; pressure: 1 atm; temperature: 308 K

Experiments:

NameSampleSample stateSample conditions
2D 1H-13C HMQCsample_1isotropicsample_conditions_1
2D 1H-13C HMQCsample_2isotropicsample_conditions_1
2D 1H-13C HMQCsample_4isotropicsample_conditions_1
2D 1H-13C HMQCsample_3isotropicsample_conditions_1
2D 1H-13C HMQCsample_5isotropicsample_conditions_1
2D 1H-13C HMQCsample_6isotropicsample_conditions_2
2D 1H-15N TROSYsample_6isotropicsample_conditions_2
3D HCCH-TOCSYsample_6isotropicsample_conditions_2
3D HN(COCA)CBsample_6isotropicsample_conditions_2
3D HCCH-TOCSYsample_6isotropicsample_conditions_2
3D HN(CA)COsample_6isotropicsample_conditions_2
3D HNCAsample_6isotropicsample_conditions_2
3D HN(CO)CAsample_6isotropicsample_conditions_2
HN(CA)CBsample_6isotropicsample_conditions_2
3D HNCOsample_6isotropicsample_conditions_2
NOESY HCHsample_7isotropicsample_conditions_2

Software:

CcpNMR - data analysis, peak picking

NMRPipe - processing

TOPSPIN - collection, processing

Chimera - data analysis

NMR spectrometers:

  • Bruker AVANCE III 600 MHz
  • Bruker AVANCE NEO 700 MHz
  • Bruker AVANCE NEO 850 MHz

Download HSQC peak lists in one of the following formats:
CSV: Backbone or all simulated peaks
SPARKY: Backbone or all simulated peaks